Don't Turn Back the Clock on Diabetes Care
In a recent opinion piece published by The Well News, George Huntley, CEO of the Diabetes Leadership Council, highlights concerns about the potential impact of including continuous glucose monitors (CGMs) and insulin pumps in Medicare’s Competitive Bidding Program beginning in 2028.
Drawing on his personal experience living with diabetes, Huntley emphasizes the critical role these technologies play in improving diabetes management and reducing hospitalizations. He warns that competitive bidding could disrupt access to essential devices, limit patient choice, and discourage innovation in diabetes care.
Huntley also points to previous challenges associated with competitive bidding for diabetes testing supplies, underscoring the importance of protecting access to high-quality products and technologies that help patients manage their conditions safely and independently.